EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark SCANCELL was filed as Word mark on 06/21/2019 at the European Union Intellectual Property Office.
It was registered as a trademark on 11/12/2019.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018085033 |
| Application date | June 21, 2019 |
| Publication date | July 30, 2019 |
| Entry date | November 12, 2019 |
| Expiration date | June 21, 2029 |
Trademark owner
Unit 202 Bellhouse Building, Sanders Road, Oxford Science Park
OX4 4GD Oxford
GB
OX4 4GD Oxford
GB
Trademark representatives
Laapersveld 75
1213 VB Hilversum
NL
goods and services
5
Pharmaceutical preparations; therapeutic preparations and substances; chemical preparations; diagnostic reagents for medical use; reagents for use in biological processing; DNA, antibodies and proteins for medical use; DNA and/or antibodies and/or proteins that express epitopes for medical use; DNA and/or antibodies and/or proteins that encode for medical use; DNA and/or antibodies and/or proteins used as vectors to target cells for medical use; DNA and/or antibodies and/or proteins that stimulate cells for medical use; DNA, antibodies and proteins for therapeutic use; diagnostic products and reagents for medical use; compounds for the treatment of cancer; vaccine preparations and substances; peptide vaccines; DNA vaccines and substances; DNA, antibodies and proteins that stimulate high-avidity T-cells responses for therapeutic and medical use, namely, for the treatment of cancer; pharmaceutical compounds for treatment of cancer; Therapeutic preparations and substances for medical use, namely, DNA, antibodies and proteins for use in expressing epitopes, for use in encoding, for use in vectoring to target cells, and for use in stimulating cells; Therapeutic preparations for use in T-cell therapy and chimeric antigen receptor T-cell therapy to treat cancer
42
Research and design in the field of drug development for the treatment of cancer; pharmaceutical research and development services; pharmaceutical testing and clinical trials; research and development in the biotechnology field; provision of information and consultancy in relation to the aforesaid services
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| December 22, 2022 | Transfer / Change of address, Published |
ID: 11018085033